Following the successful exhibition at the 2016 China (Beijing) International Intensive Animal Husbandry Exhibition (VIV) in early September, attracting the attention of many foreign merchants, on October 11, 2016, the world's most authoritative research magazine in veterinary medicine and feed additive industry, "Animal Pharm", published an in-depth thousand-character report on Guangzhou Insighter Biotechnology Co., Ltd. and its founder, Dr. Peng Xianfeng. Insighter's mission is to develop high-value innovative animal healthcare products, and its vision is to solve animal intestinal problems. The ability to continuously develop high-value original innovative molecules is the company's core competitiveness. All these ​​have attracted great attention of "Animal Pharm".

The report mentioned that Insighter is not interested in producing generic drugs with expired patents, but instead focuses on innovation and R&D. It has more than 70 PCT international patents, multiple compound inventions, and innovative products such as Tanpro, Phytomicin, Buty-ER, Superstin, and SRTA that have truly solved animal intestinal problems in the market. Insighter is convinced that with the acceleration of the pace of Insighter's development in the international market and the increase in global exposure, it will attract the attention and praise of more and more international professionals in the industry. [Insighter will participate in the EuroTier International Livestock Exhibition in Hannover, Germany in November, and will participate in the second International Symposium on Antibiotic Alternatives in Paris in December as a gold sponsor and participate in the Asian International Intensive Animal Husbandry Exhibition in March 2017 (VIV)】

Link of the report from “Animal Pharm” on Insighter: www.agra-net.com/agra/animal-pharm/interviews/chinese-company-insighter-sees-feed-additive-innovation-as-key-to-global-success-529356.htm